Host-bacteria interaction in inflammatory bowel disease

British Medical Bulletin

Volumn 88, Issue 1, 2008, Pages 95-113

  Knight, Paul ^a   Campbell, Barry J ^a   Rhodes, Jonathan M ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Autophagy; Crohn's disease; Escherichia coli; M cell; Macrophage; Ulcerative colitis

Indexed keywords

ALPHA DEFENSIN; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; BETA DEFENSIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; FRUCTOSE OLIGOSACCHARIDE; INULIN; MUCIN 3; MULTIDRUG RESISTANCE PROTEIN 1; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; RIFABUTIN; RIFAMPICIN; STREPTOCOCCUS ANTIGEN; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM; VIRULENCE FACTOR; VSL3;

AUTOIMMUNITY; BACTERIAL VIRULENCE; BACTEROIDES FRAGILIS; BIFIDOBACTERIACEAE; BIFIDOBACTERIUM; CAMPYLOBACTER; CLINICAL TRIAL; CLOSTRIDIUM; COLON MUCOSA; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; ESCHERICHIA COLI; EUBACTERIUM; FECES MICROFLORA; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HOST PATHOGEN INTERACTION; HUMAN; ILEITIS; IMMUNE RESPONSE; IMMUNE SYSTEM; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; LACTOBACILLUS; LISTERIA MONOCYTOGENES; MICROBIAL DIVERSITY; MOLECULAR RECOGNITION; MYCOBACTERIUM AVIUM; MYCOBACTERIUM PARATUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PEYER PATCH; PHAGOCYTE DYSFUNCTION; PHENOTYPE; PLANT FIBER; PRIORITY JOURNAL; PSEUDOMONAS FLUORESCENS; REVIEW; SALMONELLA; SHIGELLA; ULCERATIVE COLITIS; YERSINIA;

BACTERIA; EPITHELIAL CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, MUCOSAL; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MACROPHAGES;

EID: 57749189066     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldn038     Document Type: Review

References (53)

1. Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med, 347, 417-429.
2. Baumgart DC, Sandborn WJ (2007) Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet, 369, 1641-1657.
3. Subramanian S, Campbell BJ, Rhodes JM (2006) Bacteria in the pathogenesis of inflammatory bowel disease. Curr Opin Infect Dis, 19, 475-484.
4. Wellcome Trust Case Control Consortium (2007) Genome wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 447, 661-678.
5. Baumgart DC, Carding SZ (2007) Inflammatory bowel disease: cause and immunobiology. Lancet, 369, 1627-1640.
6. Limbergen JV, Russell RK, Nimmo ER et al. (2007) The genetics of inflammatory bowel disease. Am J Gastroenterol, 102, 2820-2831.
7. Simms LA, Doecke JD, Walsh MD et al. (2008) Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. Gut, 57, 903-910.
8. Marks DJ, Harbord MW, MacAllister R et al. (2006) Defective acute inflammation in Crohn's disease: a clinical investigation. Lancet, 367, 668-678.
9. Kufer TA, Sansonetti PJ (2007) Sensing of bacteria: NOD a lonely job. Curr Opin Microbiol, 10, 62-69.
10. Wang G, Stange EF, Wehkamp J (2007) Host-microbe interaction: mechanisms of defensin deficiency in Crohn's disease. Exper Rev Anti Infect Ther, 5, 1049-1057.
11. Marks DJ, Segal AW (2008) Innate immunity in inflammatory bowel disease: a disease hypothesis. J Pathol, 214, 260-266.
12. Harbord MW, Marks DJ, Forbes A et al. (2006) Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocytecolony stimulating factor. Aliment Pharmacol Ther, 24, 651-660.
13. Liu Y, Van Kruiningen HJ, West AB et al. (1995) Immunocytochemical evidence of Listeria, Eschericia coli and Streptococcal antigens in Crohn's disease. Gastroenterology, 108, 1396-1404.
14. Ryan P, Kelly RG, Lee G et al. (2004) Bacterial DNA within granulomas of patients with Crohn's disease - detection by laser capture microdissection and PCR. Am J Gastroenterology, 99, 1539-1543.
15. Bringer MA, Glasser AL, Tung CH et al. (2006) The Crohn's disease associated adherent invasive Eschericia coli strain LF-82 replicates within mature phagolysosomes within J774 macrophages. Cell Microbiol, 8, 471-484.
16. Rolhion N, Darfeuille-Michaud A (2007) Adherent-invasive Escherichia coli in inflammatory bowel disease. Inflamm Bowel Dis, 13, 1277-1283.
17. Mpofu CM, Campbell BJ, Subramanian S et al. (2007) Microbial mannan inhibits bacterial killing by macrophages: a possible pathogenic mechanism for Crohn's disease. Gastroenterology, 133, 1487-1498.
18. Hollander D (2001) Intestinal permeability in patients with Crohn's disease and their relatives. Dig Liver Dis, 33, 649-651.
19. Bruewer M, Samarin S, Nusrat A (2006) Inflammatory bowel disease and the apical junctional complex. Ann N Y Acad Sci, 1072, 242-252.
20. Bodger K, Halfvarson J, Dodson AR et al. (2006) Altered colonic glycoprotein expression in unaffected monozygotic twins of inflammatory bowel disease patients. Gut, 55, 973-977.
21. Rhee SH, Im E, Riegler M et al. (2005) Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation. Proc Natl Acad Sci USA, 102, 13610-13615.
22. Rhodes JM (2007) The Role of Eschericia coli in inflammatory bowel disease. Gut, 56, 610-612.
23. Eckburg PB, Bik EM, Bernstein CN et al. (2005) Diversity of the human intestinal microbial flora. Science, 308, 1635-1638.
24. Baumgart M, Dogan B, Rishniw M et al. (2007) Culture independent analysis of ileal mucosa reveals a selective increase in invasive Eschericia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISME J, 1, 403-418.
25. Swidsinski A, Loening-Baucke V, Vaneechoutte M et al. (2008) Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm Bowel Dis, 14, 147-161.
26. Kotlowski R, Bernstein CN, Sepheri S et al. (2007) High prevalence of Eschericia coli belonging to the B2 and D phylogenetic groups in inflammatory bowel disease. Gut, 56, 669-675.
27. Scanlan PD, Shanahan F, Clune Y et al. (2008) Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol, 10, 789-798.
28. Sartor RB (2008) Microbial influences in inflammatory bowel diseases. Gastroenterology, 134, 577-594.
29. Scanlan PD, Shanahan F, O'Mahony C et al. (2006) Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease. J Clin Microbiol, 44, 3980-3988.
30. Sepehri S, Kotlowski R, Bernstein CN et al. (2007) Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease. Inflamm Bowel Dis, 13, 675-683.
31. Mylonaki M, Langmead L, Pantes A et al. (2004) Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Eur J Gastroenterol Hepatol, 16, 775-778.
32. Meyer AM, Ramzan NN, Loftus EV Jr et al. (2004) The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease. J Clin Gastroenterol, 38, 772-775.
33. Dicksved J, Halfvarson J, Rosenquist M et al. (2008) Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J, 2, 716-727.
34. Saldeña TA, Saraví FD, Hwang HJ et al. (2000) Oxygen diffusive barriers of rat distal colon: role of subepithelial tissue, mucosa, and mucus gel layer. Dig Dis Sci, 45, 2108-2114.
35. Martin HM, Campbell BJ, Hart CA et al. (2004) Enhanced Eschericia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology, 127, 80-93.
36. Darfeuille-Michaud A, Boucleau J, Bulois P et al. (2004) High prevalence of adherent invasive Eschericia coli associated with ileal mucosa in Crohn's disease. Gastroenterology, 127, 412-421.
37. Nowrouzian FL, Adlerberth I, Wold AE. (2006) Enhanced persistence in the colonic microbiota of Eschericia coli strains belonging to the phylogenetic group B2: role of virulence factors and adherence to colonic cells. Microbes Infect, 3, 834-840.
38. Barnich N, Darfeuille-Michaud A (2007) Role of bacteria in the etiopathogenesis of inflammatory bowel disease. World J Gastroenterol, 13, 5571-5576.
39. Abraham C, Cho JH (2007) Bugging of the intestinal mucosa. N Engl J Med, 357, 708-710.
40. TK Dalziel (1913) Chronical interstitial enteritis. BMJ, 2, 1068-1070.
41. Feller M, Huwiler K, Stephan R et al. (2007) Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect Dis, 7, 607-613.
42. Spivak J, Landers CJ, Vasiliauskas EA et al. (2006) Antibodies to I2 predict clinical response to fecal diversion in Crohn's disease. Inflamm Bowel Dis, 12, 1122-1130.
43. Neutra MR, Mantis NJ, Frey A et al. (1999) The composition and function of M cell apical membranes: Implications for microbial pathogenesis. Semin Immunol, 11, 171-181.
44. Niedergang F, Kraehenbuhl JP (2000) Much ado about M cells. Trends Cell Biol, 10, 137-141.
45. Sansonetti PJ, Phalipon A (1999) M cells as ports of entry for enteroinvasive pathogens. Mechanisms of interaction, consequences for the disease process. Semin Immunol, 11, 193-203.
46. Fujimura Y, Kamoi R, Lida M (1996) The pathogenesis of aphthoid ulcers in Crohn's disease: correlative findings by magnifying colonoscopy, electron microscopy and immunohistochemistry. Gut, 38, 724-732.
47. Martinoli C, Chiavelli A, Rescigno M (2007) Entry route of Salmonella typhimurium directs the type of induced immune response. Immunity, 27, 975-984.
48. Niess JH, Reinecker HC (2005) Lamina propria dendritic cells im the physiology and pathology of the gastrointestinal tract. Curr Opin Gastroenterol, 21, 687-691.
49. Chieppa M, Rescigno M, Huang AY et al. (2006) Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement. J Exp Med, 203, 2841-2852.
50. Rahimi R, Nikfar S, Rezaie A et al. (2006) A meta-analysis of broad-spectrum antibiotic therapy in patients with active Crohn's disease. Clin Ther, 28, 1983-1988.
51. Subramanian S, Roberts CL, Hart CA et al. (2008) Replication of colonic Crohn's disease mucosal Escherichia coli isolates within macrophages and their susceptibility to antibiotics. Antimicrob Agents Chemother, 52, 427-434.
52. Guarner F (2007) Prebiotics in inflammatory bowel diseases. Br J Nutr, 98, S85-S89.
53. Geier MS, Butler RN, Howarth GS (2007) Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics. Int J Food Microbiol 115, 1-11.